M410, a combretastatin A4 analogue, disrupts microtubules and inhibits HIF-1α in human breast cancer cells. [electronic resource]
Producer: 20160318Description: 334-40 p. digitalISSN:- 1791-2431
- Breast Neoplasms -- drug therapy
- Cell Hypoxia -- drug effects
- Cell Line, Tumor
- Cell Proliferation -- drug effects
- Female
- Gene Expression Regulation, Neoplastic -- drug effects
- Humans
- Hypoxia-Inducible Factor 1, alpha Subunit -- biosynthesis
- Microtubules -- drug effects
- Organophosphates -- administration & dosage
- Stilbenes -- administration & dosage
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.